Your browser doesn't support javascript.
loading
APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation.
Marino, Claudia; Perez-Corredor, Paula; O'Hare, Michael; Heuer, Annie; Chmielewska, Natalia; Gordon, Harper; Chandrahas, Anita S; Gonzalez-Buendia, Lucia; Delgado-Tirado, Santiago; Doan, Tri H; Vanderleest, Timothy E; Arevalo-Alquichire, Said; Obar, Robert A; Ortiz-Cordero, Carolina; Villegas, Andres; Sepulveda-Falla, Diego; Kim, Leo A; Lopera, Francisco; Mahley, Robert; Huang, Yadong; Quiroz, Yakeel T; Arboleda-Velasquez, Joseph F.
Affiliation
  • Marino C; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Perez-Corredor P; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • O'Hare M; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Heuer A; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Chmielewska N; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Gordon H; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Chandrahas AS; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Gonzalez-Buendia L; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Delgado-Tirado S; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Doan TH; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Vanderleest TE; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Arevalo-Alquichire S; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Obar RA; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
  • Ortiz-Cordero C; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Villegas A; Grupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
  • Sepulveda-Falla D; Molecular Neuropathology of Alzheimer's Disease, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kim LA; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.
  • Lopera F; Grupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
  • Mahley R; Gladstone Institute of Neurological Disease, San Francisco, California, USA.
  • Huang Y; Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA.
  • Quiroz YT; Department of Pathology, UCSF, San Francisco, California, USA.
  • Arboleda-Velasquez JF; Department of Medicine, UCSF, San Francisco, California, USA.
Alzheimers Dement ; 20(2): 819-836, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37791598

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apolipoprotein E4 / Alzheimer Disease Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Alzheimers Dement Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apolipoprotein E4 / Alzheimer Disease Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Alzheimers Dement Year: 2024 Document type: Article Affiliation country: Country of publication: